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Comparative trials that report binary outcome data are commonly pooled in sys-
tematic reviews andmeta-analyses. This type of data can be presented as a series
of 2-by-2 tables. The pooled odds ratio is often presented as the outcome of pri-
mary interest in the resulting meta-analysis. We examine the use of 7 models for
random-effectsmeta-analyses that have been proposed for this purpose. The first
of these models is the conventional one that uses normal within-study approxi-
mations and a 2-stage approach. The other models are generalised linear mixed
models that perform the analysis in 1 stage and have the potential to provide
more accurate inference. We explore the implications of using these 7 models
in the context of a Cochrane Review, and we also perform a simulation study.
We conclude that generalised linear mixed models can result in better statisti-
cal inference than the conventional 2-stage approach but also that this type of
model presents issues and difficulties. These challenges include more demand-
ing numerical methods and determining the best way to model study specific
baseline risks. One possible approach for analysts is to specify a primary model
prior to performing the systematic review but also to present the results using
othermodels in a sensitivity analysis. Only one of themodels that we investigate
is found to perform poorly so that any of the other models could be considered
for either the primary or the sensitivity analysis.
KEYWORDS
binomial distribution, exact within-study distributions, random-effects models, statistical
computing
1 INTRODUCTION
Meta-analysis is widely used in a variety of application areas, including medicine, and now requires very little intro-
duction. Data from multiple comparative trials involving binary outcomes are very often pooled in meta-analyses. For
example, Davey et al1 found 14 886 meta-analyses with binary outcomes in the January 2008 issue of the Cochrane
Database of Systematic Reviews. The observation that so many meta-analyses of this type can be found within the
Cochrane database provides clear evidence that the situation we examine here is extremely common. We assume that all
trials compare the same pair of conditions or treatments and that there is an event of interest that gives rise to a binary
outcome. Data of this type can be set out as a series of 2-by-2 tables. Our aim is to make inferences about which group
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is more likely to experience this event. A typical example is data from several randomised controlled trials, each with a
treatment and a control group, and where the event of interest is death.
We will use random-effects models to describe this type of data, which means that we can incorporate between-study
heterogeneity into our modelling. Heterogeneity in the treatment effects is likely to occur in practice due to the inclusion
of patients from different patient populations, and variation in other circumstances thatmight influence outcomes, across
the studies. If the strong assumption that the studies estimate the same true effect is made, then a common-effect model
may be used.We suggest that random-effectsmodels are in general to be preferred to common-effectmodels because their
assumptions aremore plausible. However, determiningwhich type of random-effectsmodel should be used in application
is not straightforward and is the main subject of this paper. We will make some recommendations concerning this in the
discussion.
A variety of outcome measures are available for this type of data.2-6 These measures include the relative risk, the risk
difference and the recently proposed arcsine difference. Here, we examine random-effects models for themeta-analysis of
comparative binary data where the outcome measure is the odds ratio. The odds ratio is a very popular measure of treat-
ment effect for meta-analysis, and for statistical analysis more generally, because of its favourable statistical properties.
The relative risk is another relative measure of treatment effect that, unlike the odds ratio, does not have the advantage
of being invariant to the labelling of the event. This means that the relative risk of experiencing the event does not equal
the relative risk of not experiencing the event. Another advantage of using odds ratios is that they are valid regardless of
the type of sampling used, which is not the case for other comparative measures for binary data. However, determining
the most appropriate statistical model to use when estimating the summary odds ratio is not a trivial decision and is the
focus of this paper. The context of the application might also influence the analyst's model choice.
The most commonly used random-effects methodology for estimating the summary odds ratio involves a 2-stage
approach. In the first stage, we calculate the study specific estimated log odds ratios and their (within-study) standard
errors. In the second stage, we assume that the conventional 2-stage random-effects model describes these estimates,
so that we can pool them by taking a weighted average. The pooled estimate of the log odds ratio, and the correspond-
ing confidence interval, can then be transformed onto the odds ratio scale. This procedure is justified on the basis that
normal within-study approximations are amenable to estimated log odds ratios, so that the conventional random-effects
model, and the corresponding usual inferential procedure,7 can be applied. However, the normal approximation made
by the conventional random-effects model can be poor when the studies are small or the event is rare. This can result in
inaccurate inference.8,9
More sophisticatedmodels for random-effectsmeta-analysis,10-12 that also result in a summary log odds ratio, and hence
a summary odds ratio, have been proposed. These avoid using within-study normal approximations and so in principle
are preferable. However, as we will explain below, these methods introduce their own statistical issues. The aim of this
paper is to compare the use of 7 different random-effects models and assess their advantages and disadvantages. The
first of these models is the conventional random-effects modelling approach described above and the other models are
different forms of generalised linear mixed models. It will be of particular interest to determine whether or not the more
sophisticated models can improve upon the conventional model that is very widely used in application. If this is so, then
the case for applied groups, such as Cochrane, updating their statistical practices is strong. If however the conventional
model is found to be adequate then itmay be that, rather than focussing on improving the statisticalmethods, such groups
would better spend their energies on further improving other aspects of the systematic review process.
The rest of the paper is set out as follows. In Section 2, we show an illustrative dataset and we also introduce some
mathematical notation. In Section 3, we describe the 7 statistical models that we examine in this paper. In Section 4, we
discuss the issues and concerns that accompany the use of these 7 models. In Section 5, we explore the implications of
using these models in the context of a Cochrane Review, and in Section 6 we perform a simulation study. We conclude in
Section 7 with a short discussion.
2 AN ILLUSTRATIVE DATASET AND MATHEMATICAL NOTATION
We begin with an artificial example to show the type of data that will be analysed and the mathematical notation that will
be used to describe the statistical models. In Table 1, we show an illustrative dataset that involves 4 studies. Each study
involves both treatment groups so that there are 8 observations in total. Let i = 1 · · · k denote the study and j = 0, 1 denote
the treatment group, where j = 0, 1 indicate the “control” and “treated” group, respectively. We denote the number of
patients and events in the ith study and jth treatment as nij and eij, respectively. We use covariates j, xij, and zij in our
models, where xij is an indicator for the control group and zij = j−0.5. In the columnheadings of Table 1, aswell as showing
our mathematical notation, we also show the column names that will be used in our computing syntax. For example, in
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TABLE 1 An illustrative dataset. Two sets of column headings are
shown. The first set shows the mathematical notation used to describe
statistical models. The second set shows the column names of the
corresponding R data frame
Study (i) Treatment ( j) nij eij xij zij
study treat n event control treat12
1 0 377 113 1 −0.5
1 1 377 128 0 0.5
2 0 40 4 1 −0.5
2 1 41 6 0 0.5
3 0 100 20 1 −0.5
3 1 101 22 0 0.5
4 0 1010 201 1 −0.5
4 1 1001 241 0 0.5
TABLE 2 Another way to set out the illustrative
dataset. This is the data format required by the
metafor package to fit some models
Study (i) A B C D
1 128 249 113 264
2 6 35 4 36
3 22 79 20 80
4 241 760 201 809
Table 1, we can see that j, the indicator for the treatment group, is referred to as “treat” in the computing syntax. These
alternative ways of expressing important quantities mean that we can use conventional mathematical notation when
presenting statistical models and also meaningful syntax when fitting them. The statistical package R13 will be used to
perform all computing, where our R dataframes have the second set of column names shown in Table 1.
We use 𝜋ij to denote the probability of an event in the ith study and jth treatment group. For many models, we will
describe binomial data directly, like that in Table 1, and so we will often assume that eij ∼ Bin(nij, 𝜋ij) with a suitable
expression for 𝜋ij.
An alternative way of setting out the data in Table 1 is shown in Table 2. Here, A and B are the number of events, and
nonevents, in the treated group, respectively. Similarly, C and D are these same quantities in the control group. Table 2
is just a very simple rearrangement of the data shown in Table 1. This is necessary because the methods implemented by
the metafor package,14 that constitute some of the methods that we will investigate below, require the data to be set out
in this way. Version 1.9-9 ofmetafor was used throughout.
3 SEVEN STATISTICAL MODELS
Now that we have introduced our notation, we will introduce 7 statistical models. The first model is the conventional
random-effects model that uses normal within-study approximations for the study specific estimated log odds ratios. The
other models are generalised linear mixed models. We consider these particular alternative models because they have
either been previously suggested in the literature (models 2, 6, and 7), implemented in themetafor package14 in R (models
4 and 5) or involve a particularly natural combination of modelling ideas from other models (model 3). We restrict our
investigation to these alternativemodels because they are closely related to the conventional random-effectsmodel, where
we assume that the study specific true odds ratios, 𝜃i, are normally distributed.We suspect therefore that applied analysts,
who wish to consider an alternative to the conventional model, are most likely to adopt one of these models. However,
further models and methods are also available for analysts who are prepared to deviate further from the more usual
methods for random-effects meta-analysis, for example, see Kuss15 for a wide range of other possibilities.
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3.1 Model 1: the conventional random-effects model
The conventional random-effects model uses 2 stages. In the first stage, we estimate the study specific empirical log odds
ratios, yi, and their within-study variances, s2i . In the second stage, we assume the conventional random-effects model
7,16:
𝑦i|𝜃i ∼ N(𝜃i, s2i ) and 𝜃i ∼ N(𝜃, 𝜏2), so that marginally 𝑦i ∼ N(𝜃, s2i + 𝜏2). We treat the s2i as fixed and known. We refer to the
distributional assumption for yi|𝜃i as the within-study normality assumption; all models that follow below avoid using
this approximation. Here, 𝜃i is the true underlying log odds ratio for the ith study, so that 𝜃i = logit(𝜋i1) − logit(𝜋i0), and
𝜏2 = Var(𝜃i) is the between-study variance. The parameter 𝜃 is the summary log odds ratio. We exponentiate estimates
and bounds of confidence intervals for 𝜃 to obtain inferences on the odds ratio scale.
3.1.1 Fitting model 1
In the notation of Table 2, the estimated log odds ratios are given by 𝑦i = log((Ai∕Bi)∕(Ci∕Di)). We also calculate the
correspondingwithin-study variances in the first stage; for this, we use the standard formula s2i = 1∕Ai+1∕Bi+1∕Ci+1∕Di.
We will use the metafor escalc command (with its defaults) for these purposes throughout. This means that halves are
added to all counts in 2-by-2 tables that contain a zero entry but other tables are not modified in this way.
We conventionally estimate 𝜏2 and then treat this parameter as fixed and known when making inferences about the
log odds ratio 𝜃 and hence inferences about the odds ratio, in the second stage. The conventional methodology is then
straightforward (eg, Higgins et al7: Section 3.2). Although modifications of the usual random-effects methodology have
been proposed,17,18 we follow the most conventional random-effects methods to provide results that can be compared to
those from other models.
A wide variety of estimators of 𝜏2 are available.19 The DerSimonian and Laird20 estimator is so ubiquitous in application
(because it is currently the default in many standard software packages for meta-analysis) that we present results using
this method, where we truncate this estimator to 0 in situations where it would otherwise be negative. The DerSimonian
and Laird estimator matches a weighted sum of squares of the yi to its expectation under model 1, where the weights are
the reciprocals of the s2i . However, DerSimonian and Laird
20 also considered the use of unweighted and likelihood-based
estimators of 𝜏2. The restricted maximum likelihood (REML) estimator19,21 uses a modification of the usual likelihood to
compensate for the fact that maximum likelihood estimates of unknown variance components tend to be biased down-
wards. However, the standard theory of REML requires normally distributed outcome data. We consider REML to be the
most suitable likelihood-based implementation of model 1, so that the most appropriate comparison between the results
from this model and those that follow is obtained by using REML.
Model 1 will already be very familiar tometa-analysts and can be implemented inmost standardmeta-analysis software
packages. Here, we use the rma.uni command from themetafor R package for this purpose.
3.2 Model 2: the Simmonds and Higgins model
The next 6 models are less familiar, but closely related, generalised linear mixed models as described in the framework of
Turner et al.22 Particular types of these models have subsequently been specifically proposed or implemented in software
by others. We will attribute the models that follow to later authors and software packages, but much of what follows was
anticipated by Turner et al.22 As we will explain, models 3 and 5 are special cases of model 6. Hence, many analysts are
likely to prefer model 6 to these alternatives on the grounds that it avoids making unnecessary assumptions. We return
to this issue later.
Simmonds and Higgins10 propose the model
logit(𝜋i𝑗) = 𝛾i + 𝑗𝜃i,
where 𝜃i ∼ N(𝜃, 𝜏2) and all 𝜃i are independent. The 𝛾 i are fixed effects (unrelated constants) that describe the baseline risks
of the event in each study.10 See Simmonds andHiggins' Equations (1) and (2) where they use amore general link function
g(·) instead of logit(·), but here, we restrict ourselves to the logistic link because the odds ratio is used. An equivalent way
to express this model, which is more directly related to the syntax used by the glmer function in R, is
logit(𝜋i𝑗) = 𝛾i + 𝑗𝜃 + 𝑗𝜖i, (1)
where 𝜖i ∼ N(0, 𝜏2) and all 𝜖i are independent. Since 𝜃i = logit(𝜋i1) − logit(𝜋i0) = 𝜃 + 𝜖i, we have that E[𝜃i] = 𝜃 and
Var[𝜃i] = 𝜏2, so that 𝜃 and 𝜏2 continue to represent the summary log-odds ratio, which can be transformed to the odds
ratio scale, and between-study variance, respectively. This also applies to the next 3 models.
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3.2.1 Fitting model 2
Models 2 to 7 are generalised linear mixed models which are usually fitted using maximum likelihood estimation. The
maximisation of the likelihood required to fit these models is performed numerically and so may be fragile. We return
to this issue below. As explained by Simmonds and Higgins,10 upon loading the lme4 package23 (version 1.1-12 was used
throughout), model 2 can be fitted in R using maximum likelihood estimation by specifying the logistic mixed-effects
regression model
glmer(cbind(event,n-event)~factor(study)+factor(treat)+(treat-1|study),data=thedata1,
family=binomial(link="logit")),
where “thedata1” is a dataframe containing columns of data as shown in the second set of column headings in Table 1.
For this, and the models that follow, the regression coefficient associated with factor(treat) is the summary log-odds ratio
?̂?. The reported random-effects variance is 𝜏2. Inferences using this model (for example, standard errors and confidence
intervals), and all those that follow, are made using the asymptotic theory of maximum likelihood.
Because j is an indicator, “factor(treat)” can be replaced with “treat,” but we retain the syntax factor(treat) from Sim-
monds and Higgins10 to be consistent with their code. Also, an alternative parameterisation without an intercept can be
used when calling glmer (by adding “−1” to the linear predictor), so that the coefficients associated with factor(study) are
then immediately the estimates of 𝛾 i. Instead, including the intercept in the way shownmeans that (k−1) dummy covari-
ates are associated with “factor(study).” Using this alternative parameterisation may result in slightly different estimates
that agree to within numerical error.
3.3 Model 3: Simmonds and Higgins' model with random-study specific effects
An alternative to using fixed effects for the 𝛾 i in (1) is to instead assume that they are random-effects 𝛾 i ∼ N(𝛾, 𝜎2). In this
model, we assume that all 𝛾 i and 𝜖i are independent. We will discuss the advantages and disadvantages of using fixed and
random 𝛾 i in Section 4.
3.3.1 Fitting model 3
This model can be fitted as
glmer(cbind(event,n-event)~(1|study)+factor(treat)+(treat-1|study), data=thedata1,
family=binomial(link="logit")),
where the model intercept is 𝛾 . Now, there are 2 random-effects variances in the model: the one associated with
“(treat-1|study)” continues to be 𝜏2 and the one associated with “(1|study)” is 𝜎2.
3.4 Model 4: a modified version of Simmonds and Higgins model
Amodified version of the Simmonds and Higgins model (1) is the model
logit(𝜋i𝑗) = 𝛾i + 𝑗𝜃 + zi𝑗𝜖i. (2)
We include this model because it has been implemented in themetafor package.
In Equation 2, we can replace j𝜃 with zij𝜃 = ( j − 0.5)𝜃 without changing the form of the model. This is because if we
write logit(𝜋ij) = 𝛾 i + zij𝜃 + zij𝜖i, and then take 𝛾∗i = 𝛾i − 0.5𝜃, then we obtain (2) where 𝛾 i is now 𝛾
∗
i . Hence, replacing
j𝜃 with zij𝜃 in (2) is just a model reparameterisation. However, replacing j𝜖i in (1) with zij𝜖i to obtain (2) results in a
different model, as we demonstrate by examining the implied covariance structure under these models in the paragraph
immediately below. The subtle point is that the decision to use j or zij is immaterial when specifying the mean but not
when describing the random effects. Hence, we modify (1) by replacing only the second j with zij to obtain model 4 as
shown in Equation 2. Some readers may prefer model 2 to model 4, on the grounds that the heterogeneity component
then more clearly represents heterogeneity in the treatment effects. However, we will see below that there are statistical
reasons for preferring model 4; indeed, this is an important conclusion from this paper.
Models 2 and 4 appear very similar. The difference between these models is most clearly seen from the bivariate repre-
sentation of the log odds of an event in the control and treatment groups of the ith study. From Equation 1, for model 2,
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we have (
logit(𝜋i0)
logit(𝜋i1)
)
∼ N
((
𝛾i
𝛾i + 𝜃
)
,
(
0 0
0 𝜏2
))
,
and from Equation 2, for model 4, we have(
logit(𝜋i0)
logit(𝜋i1)
)
∼ N
((
𝛾i
𝛾i + 𝜃
)
,
(
𝜏2∕4 −𝜏2∕4
−𝜏2∕4 𝜏2∕4
))
.
For both models, we have E[𝜃i] = 𝜃 and Var[𝜃i] = 𝜏2, but models 2 and 4 assume different bivariate structures.
3.4.1 Fitting model 4
This model can be fitted usingmetafor as
rma.glmm(measure="OR", ai=A, bi=B, ci=C, di=D, data=thedata2, model="UM.FS"),
where “thedata2” is a dataframe with columns set out as in Table 2. Here “UM.FS” indicates an unconditional model
and fixed-study effects 𝛾 i.Metafor's alternative conditional (on the total number of events) model is presented as model 7
below. This model can also be fitted using glmer, for example, as
glmer(cbind(event,n-event)~factor(study)+factor(treat)+(treat12-1|study),
data=thedata1, family=binomial(link="logit")).
In fact, the rma.glmm command calls glmer from the lme4 package to fit this and the next model.
3.5 Model 5: a modified version of Simmonds and Higgins model with random-study
specific effects
As in the Simmonds and Higgins model, an alternative to model 4 is to assume that 𝛾 i ∼ N(𝛾, 𝜎2) in (2). This model
has also been implemented in the metafor package. As is the case for model 3, it is immaterial whether we write j𝜃 or
zij𝜃 = ( j−0.5)𝜃when specifying themodel, because insteadwriting 𝜃zij is amodel reparameterisationwhere 𝛾∗ = 𝛾−0.5𝜃.
3.5.1 Fitting model 5
This model can be fitted usingmetafor as
rma.glmm(measure="OR", ai=A, bi=B, ci=C, di=D, data=thedata2, model="UM.RS"),
where “UM.RS” now indicates an unconditional model and random-study effects 𝛾 i. As for the previous model, this can
also be fitted using glmer which is called by the rma.glmm command, for example, as
glmer(cbind(event,n-event)~(1|study)+factor(treat)+(treat12-1|study),
data=thedata1, family=binomial(link="logit")).
3.6 Model 6: the “Van Houwelingen bivariate” model
This model was originally proposed by VanHouwelingen et al11 and has also been presented by Stijnen et al.12 This model
describes the joint distribution of the probability of an event in the treatment and control groups in each study. Specifically,
this model assumes that (
logit(𝜋i0)
logit(𝜋i1)
)
∼ N
((
𝛾
𝛾 + 𝜃
)
,
(
𝜎20 𝜌𝜎0𝜎1
𝜌𝜎0𝜎1 𝜎
2
1
))
, (3)
where we have reparameterised the mean differently to the previous descriptions of this model, so that 𝜃 continues to
represent the log odds ratio. We now have
𝜏2 = Var(𝜃i) = Var(logit(𝜋i1) − logit(𝜋i0)) = 𝜎20 + 𝜎21 − 2𝜌𝜎0𝜎1. (4)
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We can also present models 3 and 5 in the bivariate form shown in Equation 3. From Equations 1 and 2, with the
assumptions that 𝛾 i ∼ N(𝛾, 𝜎2) and 𝜖i ∼ N(0, 𝜏2), where these random effects are independent, we can write model 3 as(
logit(𝜋i0)
logit(𝜋i1)
)
∼ N
((
𝛾
𝛾 + 𝜃
)
,
(
𝜎2 𝜎2
𝜎2 𝜎2 + 𝜏2
))
(5)
and model 5 as (
logit(𝜋i0)
logit(𝜋i1)
)
∼ N
((
𝛾
𝛾 + 𝜃
)
,
(
𝜎2 + 𝜏2∕4 𝜎2 − 𝜏2∕4
𝜎2 − 𝜏2∕4 𝜎2 + 𝜏2∕4
))
. (6)
See also table V of Turner et al22 for (5) and (6), where these results are also given. From the bivariate representation
of models 3 and 5 in (5) and (6), we can see that model 6 is a generalisation of both of these models. Compared to model
6, models 3 and 5 impose constraints on the covariance structure of the true underlying log odds of an event in the 2
treatment groups, whilst ensuring that 𝜏2 = Var(𝜃i). Also from (5), we can easily derive that the true treatment effect
in the ith study, logit(𝜋i1) − logit(𝜋i0), is independent of logit(𝜋i0) in model 3. Furthermore, from (6), we can derive that
logit(𝜋i1) − logit(𝜋i0) is independent of logit(𝜋i1) + logit(𝜋i0) in model 5. No such independence structure is imposed by
model 6. The difference between models 2 and 4 is analogous to that between models 3 and 5.
3.6.1 Fitting model 6
This model can be fitted as
glmer(cbind(event,n-event)~factor(treat)+(control+treat-1|study), data=thedata1,
family=binomial(link="logit")),
where we calculate the estimate of 𝜏2 from the estimated variance components associated with (control + treat-1|study)
as shown in Equation 4.
3.7 Model 7: the “hypergeometric-normal” model
This model was also proposed by Van Houwelingen et al11 and Stijnen et al.12 Upon conditioning on the total number of
events all marginal totals of the 2-by-2 tables are fixed. Then, each table can be specified in terms of the number of events
in the treatment group, ei1, and we have
P(Ei1 = ei1|𝜃i) =
(
ni1
ei1
)(
ni0
ti − ei1
)
exp(𝜃iei1)
∑
𝑗
(
ni1
𝑗
)(
ni0
ti − 𝑗
)
exp(𝜃i𝑗)
, (7)
where we define the total number of events ti = ei0 + ei1 and the summation j is over the values of ei1 that are permissible
under the table marginal totals. Equation 7 is the noncentral hypergeometric distribution. If we take the log odds ratio
in the ith study to be 𝜃i = 0, then all exponents in (7) are equal to 1 and, by Vandermonde's identity, the denominator
of (7) becomes
(
ni0 + ni1
ti
)
. Hence, (7) reduces to the much more familiar (central) hypergeometric distribution when
𝜃i = 0. The noncentral hypergeometric distribution can therefore be conceptualised as “startingwith the relativeweights,”(
ni1
ei1
)(
ni0
ti − ei1
)
, of the probabilities allocated by the (central) hypergeometric distribution. If 𝜃i > 0, the noncentral
hypergeometric distribution then gives further relative weight, and so probability, to large ei1 via the term exp (𝜃iei1). If
𝜃i < 0, the noncentral hypergeometric distribution then gives less relative weight to large ei1 via this term.
Upon assuming that 𝜃i ∼ N(𝜃, 𝜏2) and integrating out the random effects, we obtain the probability distribution of the
ith table as
∞
∫
−∞
P(Ei1 = ei1|x)1
𝜏
𝜑((x − 𝜃)∕𝜏)dx,
so that the likelihood is the product of terms of this type. The above integral is computationally more stable upon substi-
tuting z = (x − 𝜃)∕𝜏, to avoid division by a very small quantity when 𝜏2 is small. Model 7 is a mixed-effects conditional
logistic regression model.
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3.7.1 Fitting model 7
This model is implemented inmetafor as
rma.glmm(measure="OR", ai=A, bi=B, ci=C, di=D, data=thedata2, model="CM.EL"),
where “CM.EL” indicates conditional model and exact likelihood.
3.7.2 An approximate version of model 7 when the event is rare
It is also possible to implement an approximate version of this model where it is assumed that the event is rare.12 First,
note that if the event is rare, then the summation in the denominator of (7) is from j = 0, 1, 2, · · · , ti. The result needed
for the approximation is that, if y ≪ n, then
(
n
𝑦
)
≈ n𝑦∕𝑦! Then in the summation in the denominator of (7), we can
approximate (
ni1
𝑗
)(
ni0
ti − 𝑗
)
≈
n𝑗i1
𝑗!
nti−𝑗i0
(ti − 𝑗)!
=
(
ni1
ni0
)𝑗 ntii0ti!
𝑗!(ti − 𝑗)!ti!
=
(
ni1
ni0
)𝑗 ( ti
𝑗
) ntii0
ti!
,
which, upon setting j = ei1, for the numerator of (7) gives(
ni1
ei1
)(
ni0
ti − ei1
)
≈
(
ni1
ni0
)ei1 ( ti
ei1
) ntii0
ti!
so that (7) is approximately
P(Ei1 = ei1|𝜃i) =
(
ti
ei1
)
(ni1 exp(𝜃i)∕ni0)ei1
∑ti
𝑗=0
(
ti
𝑗
)
(ni1 exp(𝜃i)∕ni0)𝑗
.
Next, we divide top and bottom by (1 + ni1 exp(𝜃i)∕ni0)ti and define 𝜋i = (ni1 exp(𝜃i)∕ni0)∕(1 + ni1 exp(𝜃i)∕ni0), so that
P(Ei1 = ei1|𝜃i) =
(
ti
ei1
)
𝜋
ei1
i (1 − 𝜋i)
ti−ei1
∑ti
j=0
(
ti
𝑗
)
𝜋
𝑗
i (1 − 𝜋i)ti−𝑗
.
The denominator of this expression is the sum over all the probabilities of a Bin(ti, 𝜋i) distribution and so is one. The
numerator is the probability of observing ei1 from this same distribution. Hence, if the event is rare, we can replace the
hypergeometric density (7) with a much simpler binomial probability P(Ei1 = ei1|𝜃i)where Ei1|𝜃i ∼ Bin(ti, 𝜋i). This is the
same as expression (11) in Stijnen et al.12
We can write 𝜋i = expit(log(ni1∕ni0) + 𝜃i), where expit(·) is the inverse of the logit(·) function, so that the log odds of
an event in the approximate model Ei1|𝜃i ∼ Bin(ti, 𝜋i) is log(ni1∕ni0) + 𝜃i. As we assume that 𝜃i ∼ N(𝜃, 𝜏2), we can fit
this approximate model as an intercept only logistic mixed-effects regressionmodel. Here, each study contributes a single
binomial outcome where there are ei1 events in ti trials, we specify an offset of log(ni1∕ni0) and we include a random
intercept in the model. Themetafor package implements this approximate model using the syntax
rma.glmm(measure="OR", ai=A, bi=B, ci=C, di=D, data=thedata2, model="CM.AL"),
where “CM.AL” indicates conditional model, approximate likelihood. The intuition behind using a binomial approxima-
tion when the event is rare is because it is then of little consequence whether or not the model allows for the sampling
to be performed with replacement. This type of approximation is used in many Cox regression and conditional logistic
regression computer programs to avoid more numerically demanding exact likelihoods.
3.7.3 Presenting a random-effects implementation of the Peto method as an
approximate version of model 7
Using the noncentral hypergeometric distribution is challenging numerically, and so it is desirable to have approximate
methods that are numerically simpler to implement and so will bemore robust.When the event is rare, then the approach
suggested in the previous section can be used for this purpose. However, when the event is more common the large table
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entriesmake the computation evenmore challenging and anothermethod is needed. In this section, we propose amethod
that can be used as a “sanity check,” to ensure that the results from model 7 are reliable.
The pooled log odds ratio using the Peto method24 is a 1-step estimate of the log odds ratio, where we assume both the
noncentral hypergeometric distribution (7) and a common-effect model and take a single iteration using Fisher scoring
method25 starting at 𝜃 = 0. Thismeans that the Petomethod implements an approximate version ofmodel 7 where 𝜏2 = 0.
We however adopt a random-effects approach.
To include random effects in a computationally straightforward way, we can take the study specific estimated Peto log
odds ratios to represent the within-study information contained in the noncentral hypergeometric distributions in (7).
These estimated log odds ratios can be obtained using the escalc function and measure=“PETO.” Then using normal
approximations for these estimated Peto log odds ratios, we can fit an approximate version of model 7 using the con-
ventional random-effects model (model 1) and the estimated Peto log odds ratios as outcome data. Maximum likelihood
estimation is used when fitting model 7, and so we should estimate 𝜏2 by maximum likelihood when using the conven-
tional model in this way to most accurately reproduce the results from model 7. This is easily implemented by taking
using method=“ML” when using the rma.uni function to fit the standard random-effects model.
The advantage of this approximate approach is that, unlike when fitting model 7 directly, the numerical methods
required are very robust and convergence difficulties are rare. This approximate approach for fitting model 7 is especially
useful to supplement simulation study results in situations where the estimation of this model fails, as we explain below.
In applied work, more generally, we suggest that fitting the conventional random-effects model to the estimated Peto log
odds ratios, using maximum likelihood estimation for 𝜏2, is a practical way to assess if the sometimes numerically fragile
results frommodel 7 are correct. If the numerical algorithms are successful and the estimated effect is not very large then
these approximate inferences should be reasonably similar to those from model 7.
4 PROPERTIES OF THE STATISTICAL MODELS
Before we examine the implications of these statisticalmodels empirically and via simulation studies, we discuss themain
issues and concerns that relate to them.
Model 1, the conventional random-effects model, has the advantages of being already familiar to meta-analysts and
very simple. However, the accuracy of the within-study normality assumptions is often poor in practice which makes
this approach open to criticism. The main reason for including this model is to see whether or not generalised linear
mixed models, that avoid this type of normal approximation, can result in any notable improvement. Model 1 provides
the current standard practice to compare the other models to.
Models 2 and 4 are conceptually very similar and both present a difficulty associated with using fixed effects for the
𝛾 i.26 This is because there is then a separate parameter 𝛾 i for each study, so that if there are k studies, then there are k+ 2
parameters to estimate (the 𝛾 i, 𝜃 and 𝜏2). Each study provides 2 observations: the number of treatment and control group
events, so that we have 2k observations to estimate these k + 2 parameters. The model is therefore identifiable if k ≥ 2,
but the statistical issue is that the number of parameters increases at the same rate (ie, linearly) as the number of studies.
Hence, as the sample size (the number of studies) becomes large, the number of parameters to estimate also becomes
large. The asymptotic theory of maximum likelihood requires that the model, and so the number of parameters, is fixed
as the sample size tends towards infinity, and this is not the case here (unless the number of studies is held fixed and the
number of patients in them is allowed to tend towards infinity). Models 2 and 4 therefore do not satisfy the regularity
conditions required for maximum likelihood estimation to possess its usual good properties. This suggests that any form
of good classical estimation for these 2 models is likely to be challenging. Models 2 and 4 closely resemble models for
Bayesian random-effects models for meta-analysis,27 which may have inspired the development of these classical models.
Models 3, 5, and 6 are also conceptually similar, and as explained above, model 6 is a generalisation of both of these
other models. These models avoid the difficulty presented by models 2 and 4 because the number of parameters is fixed
for all k. However, this is at the cost of making a distributional assumption about the control group rates; as shown in
Section 3.6, models 3, 5, and 6 assume that the logit(𝜋i0) are normally distributed. Then, as Senn28 points out, bias may
result from the recovery of intertrial information. Compared to models 2 and 4, models 3, 5, and 6 can be thought of
as solving a problem by introducing another. For example, we will see in our empirical investigation in Section 5 that
“double-zero” (no events) studies contribute information about 𝜃 in models 3, 5, and 6 via intertrial information.
Finally, the hypergeometric-normal model (model 7) requires conditioning on the total numbers of events. The statisti-
cal principles that justify this conditioning are subtle, but an accessible account is given by Choi et al.29 As they point out,
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“opponents of conditioning argue that we cannot condition on the observed success total since it is not a perfect ancillary
statistic … proponents argue that per the Conditionality Principle, the inference should bemade by conditioning on the
observed success totals which are approximately ancillary with little loss of information.” Choi et al also state that the
Ancillarity Principle that is used to justify conditioning on an ancillary statistics is “generally less accepted than the idea
of using a marginal density or likelihood based on a sufficient statistic.” Model 7 could therefore be criticised by those
who do not accept the Ancillarity Principle or more practically on the grounds that some information is lost when using
this model. However, those who might object to model 7 on these grounds would presumably also object to other closely
related and well-established statistical methods, such as Fisher exact test.
A further concern that accompanies the use of generalised linear mixed models, and therefore models 2 to 7, is that
numerical maximisation of the nonnormal likelihood is needed to perform the estimation. This maximisation may be
fragile. Furthermore, the random effects must be integrated out of the likelihood numerically, and this is computationally
intensive and can be slow. When using the lme4 andmetafor packages, we must choose a value for the variable “nAGQ,”
the number of points per axis for evaluating the adaptive Gauss-Hermite approximation to the log-likelihood. The default
is 1whenusing lme4, which corresponds to theLaplacian approximation.However, the default is 7whenusing themetafor
package to fit models 4 and 5. To fairly compare results using models fitted using these packages, the same criterion
for determining nAGQ should be used. We made the pragmatic decision to use the metafor default of “nAGQ=7” for
generalised mixed models with 1 random effect (models 2, 4, and 7) and the lme4 default of “nAGQ=1” for models with 2
random effects (models 3, 5, and 6). This decisionwasmade to reduce the computational demands of the simulation study,
so that the fitting of manymodels that require integrating out 2 random effects from the likelihood is not computationally
prohibitive.We return to this issue in the discussion. There is another tension between the defaults of the lme4 andmetafor
packages, in that the latter package's default when calling rma.glmm is to drop any studies where no event occurs prior to
performing the analysis (“drop00=TRUE”). However, unless these studies are directly removed by the analyst, the glmer
command in the lme4 package includes these studies in themodel fitting. Since studieswhere no events occur contain very
little information about relative treatment effects, such as the odds ratio, this difference between the default behaviours
of the rma.glmm and glmer functions is not likely to have important consequences. However, we return to this issue in
Sections 5 and 6 where we see that there are some more subtle issues relating to this point. The main observation is that
all models are open to some form of criticism. The empirical and simulation studies that follow will examine whether or
not these concerns have serious consequences in practice.
5 THE IMPLICATIONS OF USING THE STATISTICAL MODELS IN THE
CONTEXT OF A COCHRANE REVIEW: ANTIBIOTICS FOR PREVENTING
COMPLICATIONS IN CHILDREN WITH MEASLES
To explore the practical consequences of the modelling used, we conducted an empirical investigation using a Cochrane
Review. The review Antibiotics for Preventing Complications in Children With Measles30 was selected for this purpose
because the odds ratio was used as the outcome measure, and this review was considered fairly typical of what is likely to
be encountered in practice: The review includes multiple outcomes of interest, where relatively small numbers of studies
contribute to each meta-analysis. In this empirical evaluation, we examined only the primary analyses (1.1-1.7). These
analyses consist of comparing antibiotics to placebo or no antibiotic for different binary adverse events. The review also
contained 23 further analyses, but these either describe baseline patient characteristics or sensitivity analyses. An unusual
aspect of this review is the heterogeneous nature of the contexts in which the trials were performed: One study was con-
ducted in India in the 1960s, another was conducted in West Africa in 2006, and the other 5 were performed in Glasgow,
London and or New York30 between 1939 and 1954.
5.1 Description of data
The binary outcomes of interest in the review are (1) the development of pneumonia, (2) the development of diarrhoea, (3)
the development of conjunctivitis, (4) the development of otitis media, (5) the development of croup, (6) the development
of tonsillitis, and (7) death. Some of the included studies did not report results on all outcomes, so that the analyses contain
differing numbers of studies. The data were taken directly from the Cochrane Review and are shown in Table 3, set out
as in Table 2. The order in which the studies are listed in this table is different across outcomes; this was also the case in
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TABLE 3 Datasets used in empirical investigation, taken
from Antibiotics for Preventing Complications in Children
With Measles.30 Format matches that of Table 2
Outcome Study A B C D
1 (pneumonia) Karelitz, 1954 1 155 12 69
Karelitz, 1951 0 89 3 40
Garly, 2006 1 43 6 32
Prasad, 1967 13 64 27 53
Hogarth, 1939 2 157 5 165
Anderson, 1939 4 43 6 43
Gibel, 1942 6 76 0 148
2 (diarrhoea) Anderson, 1939 5 45 12 38
Garly, 2006 2 42 5 32
Hogarth, 1939 8 151 7 163
Karelitz, 1954 0 175 1 80
3 (conjunctivitis) Garly, 2006 11 33 17 20
Karelitz, 1951 0 88 0 43
4 (otitis media) Anderson, 1939 3 57 7 52
Garly, 2006 1 43 2 35
Gibel, 1942 0 195 0 180
Hogarth, 1939 5 154 12 158
Karelitz, 1951 1 85 0 38
5 (croup) Karelitz, 1951 0 87 1 42
6 (tonsillitis) Anderson, 1939 0 63 8 54
Karelitz, 1951 0 88 1 42
7 (death) Anderson, 1939 3 60 1 61
Garly, 2006 0 44 0 37
Gibel, 1942 1 199 0 201
Hogarth, 1939 0 159 0 170
Karelitz, 1951 0 89 0 43
Karelitz, 1954 0 175 0 81
Prasad, 1967 0 78 0 80
the Cochrane Review, and we retain the outcome specific ordering of treatments, so that Table 3 can more easily be seen
to be the data reported in the Cochrane Review.
An immediate observation from Table 3 is that only 3 of the outcomes include 3 or more studies where an event occurs.
Although the final outcome, death, is included in all 7 studies, death only occurs in 2 of these. Studies with no events
provide very little information about the odds ratio and are often discarded in analysis, so for some outcomes there
are effectively just 1 or 2 studies that contribute to their analyses. The generalised linear mixed models that we have
considered are, at best, extremely weakly identifiable when k = 2. Hence, estimation issues, and even failures, are almost
inevitable in these circumstances. We therefore did not attempt to fit our models to 4 of the outcomes (3, 5, 6, and 7).
In general, we cannot recommend that applied analysts attempt this for models 2 to 7 unless there are 3 or more studies
where an event occurs. This means that we only apply our methods to 3 of the outcomes (1, 2, and 4). Although this
is perhaps disappointing, this is probably typical of what is possible in practice. Of the 3 outcomes that we apply our
methods to, there is a further issue for outcome 4, where there is a single study where no event occurs. This study did
not contribute to the corresponding analysis in the Cochrane Review on the grounds that the corresponding odds ratio
is not estimable; as noted above, the default behaviour of rma.glmm is to remove these studies. We perform analyses
for this outcome both including and excluding this study to assess the impact of this decision. We report the treatment
effect estimates in terms of log odds ratios as set out in Section 3. The Cochrane Review presents results in terms of the
odds ratio but the results are easily transformed from our scale to theirs. The Cochrane Review pooled the results using a
Mantel-Haenszel random-effects method that we do not consider here; we instead use model 1 to provide a conventional
analysis to compare other results to. However, the Mantel-Haenszel method provides results that are in good agreement
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with ours. Each outcome is undesirable, andwe use log odds ratios to compare antibiotic to either placebo or no antibiotic,
where a negative estimate of treatment effect ?̂? indicates a benefit of antibiotics.
5.2 Estimation difficulties
Two minor estimation difficulties were initially encountered when performing the analyses. Firstly, for model 3 and the
first outcome (pneumonia) an artificially small standard error for ?̂? was obtained. This was corrected by increasing the
number of function evaluations allowed. Secondly, for model 7 and outcome 4, we changed the defaults to obtain conver-
gence. Specifically, we increased the maximum number of iterations to 20 000, increased the relative tolerance to 0.0001,
and used the more robust Nelder-Mead maximisation algorithm. Hence, when fitting model 7 to outcome 4, we called
rma.glmm using syntax of the form
rma.glmm(measure="OR", ai=A, bi=B, ci=C, di=D, data=thedata2, model="CM.EL",
control=list(optCtrl=list(
maxit=20000, reltol=0.0001), optmethod="Nelder-Mead")).
We also specified nAGQ=7 when fitting model 7 because this model involves a single random effect (as explained in
Section 4). However, this is just used in the computation when applying the approximate method in Section 3.7.2 to
obtain starting values for the numerical maximisation and so does not control the number of quadrature points used
when fitting this model using the metafor package. We explored the use of various alternatives to the current default
of “hessianCtrl=list(16),” to try to obtain more stable standard errors but found that this default performed well and so
retained it.
5.3 Results
The estimates of 𝜃 and 𝜏2 obtained under each model for all 3 outcomes analysed are shown in Table 4. Here, “outcome
4b” indicates the fourth outcome (otitis media) where the double-zero study was removed prior to analysis. The standard
errors of ?̂? are shown in parentheses. For all outcomes, the conclusions from all models are in broad agreement. However,
there are also some noteworthy differences between the point estimates. For example, for outcome 1 (pneumonia) models
2 and 3 result in slightly greater estimated treatment effects and for outcome 2 (diarrhoea) there are also nonnegligible
differences between the estimated effects. The estimates of 𝜏2 for outcomes 1 and 2, for which the outcome data are quite
heterogeneous as noted in the Cochrane Review (I2=63% and I2 = 25%, respectively30), are sensitive to the model choice.
However, estimates of 𝜏2 are not precise in small samples such as these. Hence, themagnitudes of the differences between
the 𝜏2 for these outcomes are not surprising.
The most interesting observations are for outcome 4 (otitis media), where we compare the results where we do, and do
not, remove the study where no events occurred. For model 1, the removal of the double-zero study results in a point esti-
mate further from the null, as should be expected. Models 2, 4, and 7 are robust to the choice of whether or not we include
this study. This is obviously inevitable for model 7 because conditioning on no events results in a degenerate distribution
that does not depend on the model parameters and so the double-zero study does not contribute to the likelihood. This
observation is, albeit less obviously, also inevitable for models 2 and 4. This is because double-zero studies provide strong
evidence that their study-specific fixed 𝛾 is are large and negative but otherwise provide negligible information about any
other model parameter.
However, the results from models 3, 5, and 6 are sensitive to the decision of whether or not to include the double-zero
study. This is also as expected, because these models assume that the control group event rates are exchangeable, so that
this study provides information about all model parameters via the recovery of intertrial information. With the exception
of model 6 when including the double-zero study (for which 𝜏2 = 0.197), all estimates of 𝜏2 are either 0 or very small,
this is, consistent with the I2 = 0 statistic for this outcome from the Cochrane Review.30 Hence, it would seem that model
6's estimate of 𝜏2, for the full dataset, is incongruous with the others. In the notation of Equation 3, model 6 provides
?̂?20 = 2.764, ?̂?21 = 1.485, and ?̂? = 1. Substituting these estimates into Equation 4 gives 𝜏2 = 0.197. However, upon removing
the double-zero study, we instead obtain ?̂?20 = 0.161, ?̂?21 = 0.114, and ?̂? = 1, which from Equation 4, we obtain 𝜏2 = 0.004.
The most substantive difference between these estimated covariance structures is that the exclusion of the double-zero
study results in a markedly smaller ?̂?20 . This can be explained because the exclusion of this study drastically reduces the
variability in the 𝛾 i, because we have removed the study where there is strong evidence that its 𝛾 i is large and negative,
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TABLE 4 Empirical investigation results. The top half of the table shows the treatment
effect estimates ?̂? and their estimated standard errors in parentheses. The bottom half shows
the estimates 𝜏2. Asterisks (*) denote cells where nondefault arguments have been used to
obtain results. Outcome 4b represents the dataset from outcome 4 with its “double-zero”
study removed
Outcome
?̂? 1 2 4 4b
Model 1 (D&L) −1.060(0.544) −0.634(0.426) −0.787(0.390) −0.815(0.397)
Model 1 (REML) −1.060(0.628) −0.658(0.459) −0.787(0.390) −0.815(0.397)
Model 2 −1.236(0.782) −0.599(0.345) −0.803(0.396) −0.803(0.396)
Model 3 −1.241(0.685)* −0.683(0.433) −0.815(0.396) −0.878(0.396)
Model 4 −1.024(0.708) −0.629(0.402) −0.803(0.396) −0.803(0.396)
Model 5 −1.071(0.717) −0.673(0.413) −0.815(0.396) −0.878(0.396)
Model 6 −1.056(0.738) −0.533(0.533) −0.505(0.743) −0.856(0.435)
Model 7 −1.143(0.888) −0.635(0.416) −0.793(0.395)* −0.793(0.395)*
Outcome
𝜏2 1 2 4 4b
Model 1 (D&L) 1.154 0.183 0 0
Model 1 (REML) 1.785 0.275 0 0
Model 2 3.224 0 0 0
Model 3 2.311* 0.105 0 0
Model 4 2.664 0.085 0 0
Model 5 2.791 0.119 0 0
Model 6 2.789 0.071 0.197 0.004
Model 7 4.341 0.099 0.001* 0.001*
Abbreviation: REML, restricted maximum likelihood.
and so ?̂?20 is smaller upon omitting this study. Issues associated with the recovery of intertrial information for models
3, 5, and 6 are exemplified by the case where a decision is made regarding whether or not to include studies where no
events occur.
The estimates of 𝜏2 using the “Peto approximation,” as described in Section 3.7.3, are 𝜏2 = 1.949, 0.069, 0, and 0. The
corresponding estimates of 𝜃, with standard errors in parentheses, are ?̂? = −0.914(0.595),−0.614(0.363),−0.747(0.359)
and −0.769(0.365). Comparing these results to those for model 7 in Table 4, we can see that the point estimates from this
approximation can provide a useful, albeit rough, check that the results from this model are correct.
The main conclusions from this empirical investigation are as follows. Firstly, there were only sufficient numbers of
studies in 3 out of 7 analyses for the more sophisticated models to be advocated. We suspect this is likely to be fairly
representative of other applications. Hence, the usefulness of the more sophisticated models 2 to 7 may be curtailed for
this reason. In fact, obtaining accurate inference using the conventional model 1 is also very challenging when there are
just a few studies31 but the numerical algorithms can be expected to be much more robust when using this simple model.
Hence, there are fewer concerns about the stability of the numericalmethods requiredwhenusing the conventionalmodel
when there are very few studies, as is commonly the case. Secondly, this empirical investigation shows that inferences
may be sensitive to modelling choice so sensitivity analysis is an attractive option. Thirdly, by considering the analyses
of outcome 4, both including and excluding the double-zero study, we have further proof of concept that models 3, 5,
and 6 can recover intertrial information. This suggests that the decision of whether or not to include studies where no
events occur should be considered carefully when using these models in application; sensitivity analysis to this decision
when using these models are therefore likely to be desirable. If sensitivity analyses are not to be considered, then we
suggest that it is better to exclude double-zero studies when fitting models 3, 5, and 6 on the grounds that otherwise the
recovery of intertrial information from these studies would be a source of considerable concern. Finally, the conventional
random-effectsmodel has provided results that are in good agreementwith the results from themore sophisticatedmodels
2 to 7 which, given the first model's wide applicability and simplicity, suggests that the conventional approach retains its
usefulness in application. We will explore this issue in more detail in the simulation study.
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5.4 Additional real examples
In the Supporting Information, we explore 2 additional real examples that have different properties to those in the
Cochrane Review described above. The first of these examples includes 45 studies. Here, because there are so many
studies, the between-study variance is better identified and all models result in the conclusion that there is no evidence of
a treatment effect. However, point estimates of both 𝜃 and 𝜏2 are somewhat sensitive to the model used, and we conclude
that sensitivity analyses retain their usefulness even in meta-analyses with large numbers of studies.
The second additional example includes 17 studies and no events occur in 5 of these. The implications of the decision
of whether or not to exclude the double-zero studies was found to be similar to those for outcome 4 (otitis media) in our
main example. In particular, models 2, 4, and 7 were not sensitive to this decision for the reasons given above. Models
3, 5, and 6 were sensitive to this decision because they recover intertrial information. However, these 3 models were not
especially sensitive to this decision, despite the fact that a more substantial number of double-zero studies contribute to
this meta-analysis. Further work is needed to better understand the conditions under which models 3, 5, and 6 are very
sensitive to the decision of whether or not to include double-zero studies.
Another observation is that for models 3 and 5, artificially small standard errors for ?̂? were initially obtained for the
second additional example upon removing the 5 double-zero studies. This was corrected by increasing the number of
function evaluations allowed, as in Section 5.2 for model 3 and the first outcome. This suggests that obtaining reliable
standard errors may be challenging when using generalised linear mixed models for meta-analysis in practice. We return
to this issue in the simulation study.
6 SIMULATION STUDY
The empirical investigation above is valuable but a simulation study was also performed to better understand the impli-
cations of using each of the models. We performed the simulation study over a range of settings designed to include
favourable and unfavourable situations for different models. We focussed on 4 main issues: estimation failure, the bias
and precision of the estimates of 𝜃 and 𝜏2, and the coverage of nominal 95% confidence intervals for 𝜃. This means that
we focus on the bias and precision of the estimated log odds ratio, rather than the odds ratio directly, but this is appropri-
ate because all inference is performed on the log odds ratio scale. Nominal 95% confidence intervals from all models are
only approximate, even for the more sophisticated models 2 to 7. This is because inference from these models is based on
the asymptotic theory of maximum likelihood. Hence, some departure from 95% coverage was anticipated when using
all models. Kuss15 also explores the use of generalised linear mixed models in a simulation study, but here we explore in
detail how variations of this type of model compare to each other. Thomas et al32 also examine 2 of the generalised lin-
ear mixed models that we consider in a simulation study (our models 4 and 5) and conclude that the results using these
models are “not importantly different.” We will see below that this is also the case in our simulation study; hence, our
findings are in agreement with this previous finding.
6.1 Simulation study design
We explored 15 simulation settings, each with 2 values of 𝜃 = 0, log(2), so that results both under and away from the
null were obtained. However, other than to provide a different location of the estimated effects, we did not expect the
value of 𝜃 to greatly influence our conclusions. This intuition was for the most part confirmed and so (with the exception
of estimation failure rates) we present the results for 𝜃 = 0 in tables in the main paper and 𝜃 = log(2) in tables in the
Supporting Information. One thousand simulated datasets were produced for each setting and value of 𝜃, so that in total,
30 000 simulated datasets were produced. Different random seeds were used for each setting and value of 𝜃, but all models
were fitted to the same simulated datasets.
6.1.1 The simulation study defaults
We initially considered the case where there are k = 10 studies, where the log odds of an event in the control group were
simulated from LOc ∼ N(logit(0.2), 0.32), the number of patientsN in the treatment groups were simulated from a discrete
uniform distribution from 50 to 500, the number of patients in the control groups are also N (so that the 2 treatment
arms in all studies contain the same number of patients), and we used a moderate 𝜏2 = 0.024. These settings provide
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our defaults. There are very many possibilities to explore, so to make the simulation study computationally feasible, we
changed just 1 (or, in the case of setting 15, two) of these defaults when considering other possibilities.
6.1.2 The event probabilities
In 10 of the simulation settings (1 to 7 and 10 to 12), we simulated the log odds of an event in the control groups
using our default of LOc ∼ N(logit(0.2), 0.32), so that the majority (96%) of control group probabilities fall within the
range [0.1, 0.3]. Hence, we simulate control group events that are unlikely to occur but are not rare. In setting 8, we
simulated LOc ∼ N(logit(0.05), 0.32), to explore the implications of the event being rarer. In setting 9, we simulated
LOc ∼ N(logit(0.01), 0.32), to explore the implications of the event being very rare. In setting 13, we simulated the prob-
ability of an event in the control group from a uniform distribution from 0.1 to 0.3, so that models 3, 5, and 6 that make
normal distributional assumptions about the control group log odds aremisspecified. In setting 14, we simulated the aver-
age (across both groups) log odds of an event as LOa ∼ N(logit(0.2), 0.32), so that data are then simulated under models 4
and 5 (instead of models 2 and 3). In setting 15, we simulated LOc ∼ N(logit(0.5), 0.32), so that events and nonevents are
approximately equally likely in control groups. As explained below, in setting 15, we explore the implications of extreme
between-study heterogeneity. By taking the control group event probabilities to be around 0.5, and then allowing the treat-
ment group probabilities to take a wide-range values (see below), we are able to invoke very considerable between-study
variation in the comparative event rates across studies.
In all but setting 14, we then simulated the log odds of an event in the treatment group as LOt = LOc + 𝜃 + 𝜏Z, where
Z ∼ N(0, 1). For setting 14, we also simulated the treatment effects as 𝜃 + 𝜏Z, but we added and subtracted half of this to
the treatment and control group event log odds, respectively. Log odds were converted to probabilities so that binary data
could be simulated using binomial distributions.
6.1.3 The numbers of patients
In 11 of the simulation settings (1 to 6, 8 to 9, and 13 to 15), we simulated the number of patientsN in the treatment group
using our default distribution, a discrete uniformdistribution from50 to 500, andwe also took the samenumber of patients
in the control groups. This produces a range of realistic study sizes where the studies are neither very small or inordinately
large, and where the 2 treatment groups are of equal size. In setting 7, we instead simulated N from a discrete uniform
distribution from 10 to 100, to explore the impact of smaller studies. It is not uncommon for meta-analyses to include
only small studies, so setting 7 represents a situation that is quite likely to arise in practice. The normal approximations
required by model 1 are really quite crude in this setting.
In the remaining 3 simulation settings (10 to 12), we explored the use of unequal group sizes (but otherwise used our
defaults). In setting 10, we set the control group size to be half that of the treatment group. This reflects the notion that 2
closely related treatment groups might be combined to form a single treatment group. In this setting, we therefore took
the number of patients in all the control groups to be N∕2, where halves were rounded to a whole number. In setting 11,
we took the number of patients in 50% (k∕2 = 5) of the control groups to be N, the same as in the treatment group, but
in the other 50% of the control groups, we took the number of patients in the control group to be N∕2. In this setting,
studies were allocated to these 2 types of study on the basis of the order in which they were simulated, so that there is no
association between the control group size and the outcome data. We did not expect this setting to result in bias for the
estimated effect when using any model.
However, in setting 12, we ranked the k = 10 true probabilities of an event in the control groups and took those whose
rank is less than equal to k∕2 = 5 to have the same number of N patients as in the corresponding treatment group. The
remaining 5 studies were instead taken to have N∕2 patients in the control group. This setting was explored as it was
thought to have the potential to result in bias in models 3, 5, and 6. This is because the distributional assumptions for the
control group event probabilities, combined with an association between event probabilities and the control group size,
were thought to be good conditions under which the recovery of intertrial information might result in bias when using
these models.
6.1.4 A typical study within-study variance
The within-study variance for an estimated log odds ratio is a function of the group sizes and the event probabilities.
Having specified the way in which we determine these quantities, we can determine a typical within-study variance. This
enables us to better understand the implications of the simulation study design.
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Taking the typical number of patients in each treatment group to be 275, and a typical event probability to be 0.2, a
representative within-study variance for the resulting estimated log odds ratios is around 2∕(275 × 0.2 × 0.8) ≈ 0.05. This
is similar to the typical within-study variance of 0.056 from the scaled and truncated 𝜒2 distribution that has sometimes
been used to simulate typical within-study variances for log odds ratios.33-36 This observation indicates that the study sizes
and probabilities of an event are reasonably consistent with what is typically observed in practice.
6.1.5 The number of studies
In 12 of the simulation settings (1 to 3 and 7 to 15), we simulate using our default of k = 10 studies. This produces
meta-analyses wheremodels are well identified but the number of studies is not unrealistically large. In the other settings
we explore the use of k = 3, 5, 20, to explore the implications of the number of studies. We consider k ≥ 3 to investigate
situations where all models are identifiable. Each study provides the treatment and control event rates, so that in total,
a meta-analysis has 2k estimates. Then, with k = 3, we have 6 estimates available and all models are, albeit weakly,
identifiable. We deliberately avoid the case where k = 2 where models may be identifiable but estimation problems are
very likely, as in the empirical evaluation in Section 5.
6.1.6 The between-study variance
In simulation settings 1 to 3, we simulate datasets with the above defaults andwith 𝜏2 = 0.024, 0, 0.168, respectively. These
values were used previously35,36 with the scaled and truncated 𝜒2 distribution described above to reflect I2 statistics37 of
0.3, 0, and 0.75. Hence, these values were chosen to be consistent with previous simulation studies35,36 and to explore
mild, no, and considerable between-study variation, respectively. In simulation settings 4 to 14, we simulated data with
our default 𝜏2 = 0.024, to explore how the methods perform when between-study heterogeneity is present but is mild.
We chose the moderate 𝜏2 = 0.024 as our default as we thought that random-effects models are most likely to be applied
in situations where between-study heterogeneity is present but moderate.
The analysis of outcome 1 in Table 4 would seem to suggest that much larger values of 𝜏2 are possible in practice.
A 95% confidence interval for 𝜏2 for this dataset, using the Q profile method,19 is (0.166, 20.492). Hence, there is very
little information about this parameter for this example. However, in Table 3, we can see that studies provide markedly
different comparative rates and it is of interest to explore extreme scenarios such as these. To investigate such a situation,
in setting 15, we simulated data using 𝜏2 = 2. As explained above, we simulate LOc ∼ N(logit(0.5), 0.32) in this setting;
taking control group event probabilities to be 0.5, thismeans that themajority (96%) of treatment event group probabilities
will lie within (0.05, 0.95). This very wide range of treatment group probabilities means that studies with very markedly
different treatment group event rates, and so comparative rates, will be commonplace in this setting. Setting 15 therefore
explores the implications of extreme between-study heterogeneity.
6.1.7 Producing outcome data
Binary outcome data were simulated using binomial distributions with the resulting group sizes and event probabilities.
For model 1, themetafor function escalc was used, with its defaults for handling zeroes, so that empirical log odds ratios
and within-study variances can be calculated and used in the conventional random-effects model. For all other methods,
the data were processed into the forms shown in Tables 1 and 2, so that models 2 to 7 can be fitted.
A summary of the 15 simulation settings is shown in Table 5, where departures from the defaults are shown in bold. In
this table,∼ U and∼ N indicate that data were simulated from a uniform and a normal distribution, respectively. LOc and
Pc indicate the log odds of an event and the probability of an event in the control group, respectively. LOa is the average
log odds across both groups. N is the number of patients in the treatment group, which is usually also the number in
the control group. k is the number of studies. NR indicates “Not Random,” which refers to the fact that in setting 12, the
studies that have smaller control groups are not chosen at random.
6.2 The implications of our defaults when fitting models
With the exception of model 7 (the numerically challenging hypergeometric-normal model), and also when correcting
standard errors for models 3, 5, and 6 in setting 9 (see below), we used the defaults of the escalc and rma.uni commands
(model 1), the glmer command (models 2, 3, and 6), and the rma.glmm command (models 4, 5, and 7), with our convention
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TABLE 5 Simulation study design. All 15 settings were performed with 𝜃 = 0 (results shown in tables in the main
paper) and 𝜃 = log(2) (results shown in tables in the Supporting Information). One thousand simulated datasets were
produced in each setting and true effect, so that in total, 30 000 datasets were produced. A different random seed was
used for each setting and value of 𝜃. All models were applied to the same datasets. This table provides an outline of the
simulation study design; see Section 6 for full details. Departures from the defaults are shown in bold
Setting k 𝜏2 Treatment Control Baseline probability Correct models
1 10 0.024 N ∼ U(50, 500) N LOc ∼ N(logit(0.2), 0.32) 2, 3, 6
2 10 0 N ∼ U(50, 500) N LOc ∼ N(logit(0.2), 0.32) 2, 3, 6
3 10 0.168 N ∼ U(50, 500) N LOc ∼ N(logit(0.2), 0.32) 2, 3, 6
4 3 0.024 N ∼ U(50, 500) N LOc ∼ N(logit(0.2), 0.32) 2, 3, 6
5 5 0.024 N ∼ U(50, 500) N LOc ∼ N(logit(0.2), 0.32) 2, 3, 6
6 20 0.024 N ∼ U(50, 500) N LOc ∼ N(logit(0.2), 0.32) 2, 3, 6
7 10 0.024 N ∼ U(10, 100) N LOc ∼ N(logit(0.2), 0.32) 2, 3, 6
8 10 0.024 N ∼ U(50, 500) N LOc ∼ N(logit(0.05), 0.32) 2, 3, 6
9 10 0.024 N ∼ U(50, 500) N LOc ∼ N(logit(0.01), 0.32) 2, 3, 6
10 10 0.024 N ∼ U(50, 500) N/2 LOc ∼ N(logit(0.2), 0.32) 2, 3, 6
11 10 0.024 N ∼ U(50, 500) N/2 and N LOc ∼ N(logit(0.2), 0.32) 2, 3, 6
12 10 0.024 N ∼ U(50, 500) N/2 and N (NR) LOc ∼ N(logit(0.2), 0.32) None
13 10 0.024 N ∼ U(50, 500) N Pc ∼ U(0.1,0.3) 2
14 10 0.024 N ∼ U(50, 500) N LOa ∼ N(logit(0.2), 0.32) 4, 5, 6
15 10 2 N ∼ U(50, 500) N LOc ∼ N(logit(0.5), 0.32) 2, 3, 6
for the value of “nAGQ” explained above. That is, when an implementation of a model using the metafor package was
available, we used it, but when this was not available, we used glmer from the lme4 package directly.
The impact of the default behaviour of rma.glmm, which removes any studies where no events occurred in either treat-
ment group prior to analysis (which is not the default of the glmer function) is negligible in 14 settings: excluding setting
9 (very rare events), only 13 studies where no events occurred were simulated across the whole simulation study (7 stud-
ies in setting 7 and 𝜃 = 0; 4 studies in setting 8 and 𝜃 = 0; 2 studies in setting 7 and 𝜃 = log(2)). However, in setting 9,
double-zero studies were unusual but not rare: 494 studies were simulated when 𝜃 = 0, and 205 studies were simulated
when 𝜃 = log(2). We produced 1000 studies for each setting and value of 𝜃, and setting 9 uses our default with k = 10, so
that these rates correspond to proportions of 494∕10000 = 4.9% and 205∕1000 = 2.1% of double-zero studies.
The nonnegligible rates of double-zero studies in setting 9 has implications for model 1. As explained above, we use the
escalc command with its defaults to obtain outcome data for this model, which means that halves are added to all entries
of tables that contain zeroes. Hence, double-zero studies are included when fitting model 1 in this way but these studies
are typically removed in practice, perhaps on the grounds that their odds ratio is considered to be “not estimable” as in the
Cochrane Review.We have established thatmodels 2, 4, and 7 are not sensitive to the decision of whether or not to include
double-zero studies. However, models 3, 5, and 6 are sensitive, and we have argued that it is probably better to exclude
double-zero studies when fitting them. These studies are excluded in our simulation study when fitting model 5 because
we use the rma.glmm command with its defaults, but including them when using our defaults with the glmer command
to fit models 3 and 6 is a cause of concern in setting 9. In Section 6.7, we will therefore investigate the implications of
instead excluding double-zero studies when fitting models 1, 3, and 6 in setting 9.
6.3 Simulation study results
We present the results in 3 sections, where we examine estimation failure, bias and precision, and the coverage proba-
bility of confidence intervals. We summarise the results for estimation failure across all simulation settings and 𝜃 in the
main paper (all 30 000 simulated datasets), but for bias and coverage probability, we show the results for 𝜃 = 0 in themain
paper (15 000 simulated datasets) and the remaining results for 𝜃 = log(2) in the Supporting Information. The simulation
studywas timed for setting 1 and 𝜃 = 0, using a computer containing an i7-4790 processor and 16 gigabytes of RAM. Com-
putation times for fitting the models to the 1000 datasets were 5 seconds (model 1, DerSimonian and Laird), 9 seconds
(model 1, REML), 6 minutes (model 2), 2 minutes (model 3); 7 minutes (model 4), 10 minutes (model 5), 3 minutes
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(model 6), and 6 hours and 4 minutes (model 7). This indicates that models 1 and 7 are easily the least, and most,
computationally demanding models to fit, respectively.
6.4 Estimation failure
As explained above, the numerical methods required when fitting generalised linear mixed models can be fragile. This is
because the likelihood must be maximised numerically and this maximisation may fail. In this section, we quantify these
difficulties and explain how we overcame these problems.
6.4.1 Model 1
For model 1, the REML estimator failed to achieve convergence in only 11 out of the 30 000 simulated datasets and,
because the estimating equation is of closed form, the DerSimonian and Laird estimator encountered no estimation fail-
ures. Although a skilled statistician could change the defaults and ultimately force convergence of the REML estimator,
because the impact of such a small proportion of estimation failures is negligible these datasets were discarded when
evaluating model 1 and REML.
6.4.2 Models 2 to 6
For model 2, estimation failure was encountered in just a single dataset and model 3 encountered no failures at all. Sim-
ilarly, models 4 and 5 encountered failures in 1 and no datasets, respectively, where the same single dataset resulted in
estimation failures for multiple models. This dataset occurred in the fourth setting, where k = 3 and 𝜏2 = 0, and the
simulated outcome data in the 3 treatment groups were all identical to the data in the corresponding control groups. It is
not surprising that small and highly homogenous datasets can result in the occasional estimation problems for this type
of model. This is because there is relatively little information available about 𝜏2 when k is small, and it is challenging to
estimate excess variance components when the data are completely homogenous. Model 6 encountered no estimation
failures. Hence, the general picture from this simulation study is that, provided that k ≥ 3, estimation failure is a very rare
event in all models except model 7. The single dataset that caused estimation problems was discarded when evaluating
the models that it resulted in estimation failure for, with negligible impact on the results.
As seen in Sections 5.2 and 5.4, artificially small standard errors for ?̂? can be obtained when fitting generalised linear
mixed models. All reported standard errors for ?̂? from models 2 to 6 were therefore checked to assess whether or not
they appeared to be reliable. With the exception of setting 9 (very rare events), all these standard errors seemed to be
appropriate. However , in setting 9, artificially small standard errors for models 3, 5, and 6 were quite common when
using the estimation defaults. Formodel 3, 74/1000 standard errors appeared to be artificially small for 𝜃 = 0, and 60/1000
standard errors appeared to be artificially small for 𝜃 = log(2). For model 5, these rates were 52/1000 and 39/1000, and
for model 6, these rates were 66/1000 and 71/1000, respectively. For models 3 and 5, all of these artificially small stan-
dard errors were corrected by increasing the number of function evaluations allowed, as in the real examples. However,
this failed to improve matters for 2 simulated datasets when fitting model 6. A pragmatic decision was made for these
2 datasets, where we also used the standard error reported by model 5 for model 6. Ultimately, estimates and reliable
standard errors could be obtained for all simulated datasets under models 2 to 6, except the single highly homogeneous
dataset in the fourth setting described in the previous paragraph.
6.4.3 Model 7
Model 7 is by far the most computationally challenging to fit, where estimation failure was fairly common across all
simulation settings. For model 7, we changed the defaults as described in Section 5.2 for outcome 4 of the Cochrane
Review. This resulted in substantially fewer estimation failures, where point estimates of 𝜃 and 𝜏2 were not obtained
in 431/30000 (1.4%) datasets; standard errors for ?̂? were not obtained in 827/30000 (2.8%) datasets. However, there was
the further difficulty in that some reported standard errors, although computed and provided, appeared to be unreliable
because they differed substantially from those from othermodels, including the Peto approximation in Section 3.7.3. Most
of these standard errors appeared to be clearly artificially low, but occasionally, a value that appeared to be too large was
produced. On a single occasion a very grossly large standard error was reported by model 7 (17.5; the largest standard
error reported by any other model was 0.09). Given that in around 1% of datasets estimates, but not standard errors,
are obtained, it is not surprising that occasional unreliable standard errors will be computed when using model 7. This
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reinforces the suggestion in Section 3.7 that it is desirable to have approximate and robust methods for fitting model 7, to
have a “sanity check” when reporting the results from this model.
A pragmatic approach for replicating the statistical expertise necessary to fit model 7 was adopted. We began by obtain-
ing results using rma.glmm with the changes to the defaults described above. Then, any missing estimates or standard
errorswere replacedwith those from the Peto approximation described in Section 3.7.3. Next, any reported standard errors
that were less than 50% of that from the Peto approximation were replaced with those from this approximation. Finally,
the grossly large standard error was also replaced with the standard error from this approximation. There was then a fur-
ther issue because we found that in 41/30000 (0.1%) simulated datasets that the standard error reported by model 7 was
more than twice that of the Peto approximation, and some of these will be erroneous. However, determining appropriate
criterion to determine erroneously large standard errors is challenging and their impact on the simulation study is negligi-
ble. These 41 large standard errors frommodel 7 were therefore retained. In total, 992/30000 (3.3%) of the standard errors
for model 7 were provided by the Peto approximation. By “supplementing” the results from model 7 with those from the
Peto approximation, estimates and standard errors could be obtained from this model for all 30 000 simulated datasets.
6.5 Bias and precision of the estimates of 𝜃 and 𝜏2
In Table 6, we show the average of the estimates of 𝜃 and 𝜏2 in all 15 simulation settings and for 𝜃 = 0. We also show the
empirical standard errors of the estimates in parentheses. We show 2 sets of results for model 1, which show the results
using the DerSimonian and Laird and REML estimators. The results for model 7 are indicated by model 7∗ in Table 6,
to emphasise that these have been supplemented with results from the Peto approximation described in Section 3.7.3, as
explained in Section 6.4.3. The Monte Carlo standard errors of the average estimates, and the empirical standard errors,
in Table 6 can be obtained as explained byWhite.38 All Monte Carlo standard errors in Table 6 (of both themean estimates
and the empirical standard errors) in settings 1 to 8 and 10 to 14 are less than or equal to 0.005, to 3 decimal places.
However, settings 9 (very rare events) and 15 (extreme between-study heterogeneity) aremore challenging situations. The
maximumMonte Carlo standard errors in these settings is 0.010 and 0.014, respectively.
6.5.1 Evidence of bias of estimates of 𝜃
There is very little evidence of bias in the estimates of 𝜃 in Table 6. The only 2 settings where bias is strongly statistically
significant (where average estimates are around 5Monte Carlo standard errors from 0) is setting 8 (where the event is rarer
but not very rare) and setting 12 (which was designed to facilitate the recovery of intertrial information and so produce
bias in models 3, 5, and 6). However, in all instances, these biases are very small and unimportant. The slight bias for
model 1 in setting 8 is possibly because the association between the log odds ratios and their within-study variances, and
so the studyweights, is strongest when the event rate is low. The generalised linearmixedmodels do not in general appear
to be very effective in removing this bias, which is perhaps disappointing. In setting 12, we observe bias exactly where we
would expect to see it, in the models that use random effects to model the control group event rate (models 3, 5, and 6).
This is further proof of concept of Senn's28 argument that bias may result from the recovery of intertrial information, but
the results also indicate that this bias is very small and so is not a serious cause of concern.
The conclusion that setting 12 results in small and unimportant, but detectable, bias in ?̂? under models 3, 5, and 6
is confirmed by the results for 𝜃 = log(2) in the Supporting Information. Most of the other conclusions for 𝜃 = 0 are
confirmed when using 𝜃 = log(2) but there are 2 exceptions. Firstly, there was no evidence of bias in setting 8 when
𝜃 = log(2). Secondly, in setting 9 (very rare events), bias towards the null (of around 0.06, which is substantial compared
to the true 𝜃 = log(2) ≈ 0.69) was detected when fitting model 1. This is an evidence that the normal approximations
used by this model are not sufficiently accurate in this setting. The other models were effective in removing this bias in
setting 9. However, some of this bias frommodel 1may be attributable from the inclusion of double-zero studies by adding
halves, and we investigate this in Section 6.7 below.
6.5.2 Evidence of bias of estimates of 𝜏2
The situation for the bias in estimates of 𝜏2 is a little more complicated. The most serious issue is for model 2, to which
we devote an entire subsection below.
When 𝜏2 is moderate or 0, model 1 results in positively biased estimates of this parameter. This makes intuitive sense
as point estimates that would otherwise be negative are truncated to 0. For example, under the assumptions of model 1,
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the DerSimonian and Laird estimator is unbiased before truncation. Hence, if model 1 describes the data well, then
positive bias after truncation is inevitable. However, when 𝜏2 is large (setting 3), we observe slight negative bias in the
DerSimonian and Laird estimator, and when 𝜏2 is extremely large (setting 15), we observe severe negative bias. These
findings are perhaps counterintuitive. However, truncation occurs less often when 𝜏2 is large, so we should expect less
positive bias in setting 3 and, in particular, setting 15. Furthermore, the conventional random-effects model only provides
an approximation; in particular, it ignores the association between the study-specific estimates and their within-study
variances, so that negative bias is possible. This is because the most extreme (by chance) outcome data yi result in smaller
table entries, and hence large s2i , and so artificially small weights in the DerSimonian and Laird estimation method. Sidik
and Jonkman39 also found negative bias in the DerSimonian and Laird estimator when simulating binary outcome data
and applying the conventional random-effects model to the resulting estimated log odds ratios. They further found that
REML reduces, but does not remove, this bias (see their table II). Hence, our results for model 1 are qualitatively in
agreement with these previous findings.
Also from Table 6, we can see that models 3, 4, 5, and 7 usually result in slight negative bias for 𝜏2. This makes intuitive
sense because maximum likelihood estimates of unknown variance components are in general biased downwards. The
settings where this is not the case are settings 7 (small studies), 8 (rare events), and 9 (very rare events). This makes sense
because we can anticipate that the between-study variance will be least precisely estimated when studies are small and/or
events are rare. This means that the constraint that 𝜏2 must be positive has more potential to overcome the tendency for
maximum likelihood estimates of variance components to be negatively biased. In setting 9, a comparison of the average
𝜏2 and the corresponding empirical standard errors indicates that these estimates are very skewed. This is especially the
case for model 7, where a single very large 𝜏2 = 23.46 was obtained. Omitting this dataset substantially changes the 0.130
(0.780) entry in Table 6 to 0.106 (0.250), but this still indicates extreme skewness. Other models also provide very large
estimates of the between-study variance (5 < 𝜏2 < 7) for this very heterogeneous dataset and the defaults of the rma.glmm
command result in a similar 𝜏2 = 22.65 for model 7. Hence, the estimate is genuine. The extreme skewness of estimates
of 𝜏2 under models 3 to 7 in setting 9 has direct consequences for their notable positive bias (see Table 6). However, both
the bias and skewness of estimates of 𝜏2 is substantially reduced in setting 9 when 𝜃 = log(2), where more events in the
treatment group are observed (see Supporting Information). Furthermore, both the bias and skewness of estimates of 𝜏2
are also very much reduced in setting 8, relative to setting 9 (for both 𝜃 = 0 and 𝜃 = log(2)), to the extent to which these
are no longer a particular source of concern. We conclude that rare events result in difficulties for estimating 𝜏2 but also
that the events must be very rare for this to be a serious cause for concern.
Model 6 is the only generalised linear mixed model that generally results in positive bias in the estimate of 𝜏2. This is
notable because, as we have explained, in general maximum likelihood estimates of variance parameters are negatively
biased. However, from (3), we can see that model 6 allows a fully unstructured covariancematrix, whereas in the bivariate
representation of models 3 and 5, we can see these other models instead place constraints on this matrix. Model 3 places
the strong constraint that the covariance is positive (𝜎2). Model 5 allows this covariance to be negative but constrains this
to be 𝜎2 − 𝜏2∕4, which is likely to be positive in the majority of settings in our simulation study where 𝜏2 is generally
smaller than 𝜎2 (recall from Table 5 that the true 𝜎2 = 0.32 inmost settings). Hence, the constraints made bymodels 3 and
5 mean that their implied ?̂? in their bivariate representation (3) is either guaranteed or likely to be positive, which means
that the final term in (4) for the estimated 𝜏2 will be negative. However, this constraint is not made by model 6, where
?̂? is likely to be imprecisely estimated and so well may be negative which would result in a larger 𝜏2. The unconstrained
nature of the covariance matrix in model 6 therefore explains why it produces appreciably larger average estimates of 𝜏2
than models 3 and 5 and so provides slight positive bias, in many settings. Furthermore, model 6 allows a full bivariate
model but in our simulation study, we produce data from reduced forms of this model, such as model 3, so that model
6 contains more variance component parameters than is necessary to describe the data. This may also contribute to the
positive bias of estimates of 𝜏2 from model 6 in some settings.
6.5.3 The bias of estimates of 𝜏2 frommodel 2 and a comparison with model 4
When the true value of 𝜏2 = 0.024, as is the case in all but settings 2, 3, and 15, average estimates of 𝜏2 that are less
than around 0.01 were obtained from model 2, which constitutes considerable negative bias. An observation that is not
revealed by Table 6 is that, in all but setting 15, it was a very rare event that the estimate of 𝜏2 from model 4 was found
to be less than the corresponding estimate from model 2. Numerically, this appeared to occur more often than described
below because occasionally, estimates from model 2 were reported that were essentially 0 and were apparently larger
than estimates from model 4 that were reported as identically 0. Upon ignoring these cases, only 2 settings produced any
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datasets where the estimate of 𝜏2 from model 4 was less than that of model 2. This happened once in setting 9, for the
very heterogeneous dataset that provided 𝜏2 = 23.46 for model 7 as described above. However, in setting 15 (extreme
between-study heterogeneity), this was commonplace [occurring 597/1000 times when 𝜃 = 0 and 693/1000 times when
𝜃 = log(2)]. We conclude that unless the data are very heterogeneous, then it is highly unlikely that the estimate of 𝜏2
from model 2 is greater than that of model 4.
The Supporting Information gives full details of a mathematical explanation of why, in most settings, the estimate of 𝜏2
frommodel 2 is less than that of model 4. Briefly, we consider a very simple special case to obtain some analytical results,
where we assume that all treatment and control arms are of similar size and that this size is large enough to use normal
approximations for all empirical log odds in all arms. This means that we can use the same within-study arm variance s2
throughout our analysis. Under these assumptions we find, in meta-analyses with a reasonably large number of studies,
that the maximum likelihood estimate of 𝜏2 under model 4 is approximately the DerSimonian and Laird estimator under
model 1. Hence, the properties of estimators under model 4 will be acceptable. However, we find that there is downward
bias in the estimate of 𝜏2 under model 2, even as the number of studies k tends towards infinity. We also find that the
estimate of 𝜏2 will be approximately s2 larger when fitting model 4 compared to model 2. In our simulation study, this
difference is around 1∕(275×0.2×0.8) ≈ 0.02 which is nicely in agreement with the downward bias in 𝜏2 that we observe
in Table 6 in the majority of settings. However, this difference is negligible in relation to the true 𝜏2 = 2 in setting 15
and our theory essentially predicts no difference between these 2 estimates in this setting. The assumptions made in our
mathematical analysis (all study arms of similar size, normal approximations for all empirical log odds) become less valid
for very large 𝜏2, and in fact the average 𝜏2 from model 2 is slightly greater than this average from model 4 in setting
15 (Table 6). Despite this, our mathematical analysis nicely supports the surprising finding that the estimate of 𝜏2 is
negatively biased by around 0.02 in the majority of settings.
In Section 4, we warned the reader that models 2 and 4 do not satisfy the regularity conditions for maximum likelihood
estimation to have its usual good properties. Our unsettling finding about the bias of the estimate of 𝜏2 under model 2
in most simulation settings would seem to be a consequence of this. Our simulation study is sufficient to identify that,
when fixed effects are assumed for the 𝛾 i, apparently innocuous assumptions about the form of the random effect can
have serious consequences for the estimation. On the basis of this simulation study, it seems that model 4 performs much
better than model 2.
6.5.4 Precision of estimates of 𝜃 and 𝜏2
The empirical standard errors of the estimates of 𝜃 in Table 6 are generally similar across all models. This is as expected
because the precision of estimates depends primarily on the data available, rather than the specific model used, but recall
that a concern was that model 7 might result in a slight loss of information by conditioning on a statistic that is only
approximately ancillary. This loss of informationwould appear to be negligible, as expected because very little information
about the odds ratio is contained in the total number of events in 2-by-2 tables. In setting 9 (very rare events), the empirical
standard errors of ?̂? are appreciably larger in models 2 to 7 than in model 1, but we will see below that nominal 95%
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FIGURE 1 Box plots of the estimates of 𝜃 (top) and 𝜏2 (bottom) from setting 1 (the defaults). The true values of 𝜃 = 0 and 𝜏2 = 0.024 are
shown as dashed lines. M1(D) and M1(R) indicate that model 1 has been fitted using the DerSimonian and Laird and the REML estimator,
respectively. M7* indicates that model 7 has been supplemented with results from the Peto approximation
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TABLE 7 Simulation study results. Actual coverage probability of 95% confidence intervals for 𝜃. The average model based
standard errors, as a percentage of the corresponding empirical standard errors, are shown in parentheses. Model 7∗ indicates
that inferences for model 7 have been supplemented with results from the ‘Peto approximation’ described in section 3.7.3, as
explained in Section 6.3
Model 1 Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7∗
Setting (D & L) (REML) (ML) (ML) (ML) (ML) (ML) (ML)
1 0.933 (98) 0.931 (98) 0.881 (81) 0.923 (93) 0.925 (94) 0.925 (93) 0.926 (97) 0.920 (94)
2 0.957 (105) 0.957 (104) 0.945 (97) 0.952 (102) 0.953 (102) 0.953 (102) 0.956 (105) 0.953 (103)
3 0.910 (94) 0.913 (95) 0.839 (80) 0.899 (90) 0.892 (90) 0.895 (90) 0.894 (90) 0.895 (91)
4 0.935 (106) 0.937 (106) 0.907 (88) 0.921 (95) 0.921 (95) 0.922 (95) 0.947 (103) 0.922 (95)
5 0.939 (104) 0.937 (104) 0.913 (89) 0.933 (99) 0.932 (97) 0.932 (97) 0.949 (103) 0.929 (98)
6 0.943 (102) 0.947 (102) 0.894 (84) 0.936 (100) 0.943 (99) 0.943 (99) 0.942 (100) 0.941 (103)
7 0.955 (105) 0.957 (105) 0.930 (92) 0.944 (98) 0.943 (100) 0.942 (100) 0.956 (104) 0.944 (100)
8 0.952 (102) 0.950 (102) 0.911 (89) 0.937 (96) 0.937 (97) 0.936 (96) 0.958 (102) 0.937 (97)
9 0.986 (121) 0.986 (121) 0.948 (95) 0.958 (99) 0.955 (102) 0.957 (103) 0.968 (102) 0.961 (101)
10 0.939 (101) 0.944 (100) 0.896 (85) 0.934 (97) 0.923 (94) 0.936 (97) 0.952 (99) 0.935 (97)
11 0.936 (101) 0.933 (101) 0.898 (84) 0.930 (97) 0.923 (96) 0.927 (98) 0.939 (100) 0.925 (98)
12 0.931 (101) 0.933 (101) 0.881 (83) 0.927 (97) 0.922 (95) 0.923 (97) 0.931 (98) 0.926 (97)
13 0.946 (101) 0.943 (101) 0.906 (85) 0.941 (97) 0.935 (97) 0.936 (97) 0.945 (99) 0.936 (98)
14 0.920 (97) 0.917 (96) 0.880 (80) 0.906 (89) 0.911 (92) 0.911 (92) 0.916 (93) 0.906 (92)
15 0.876 (84) 0.915 (98) 0.899 (92) 0.898 (93) 0.900 (92) 0.900 (92) 0.899 (92) 0.901 (94)
Abbreviation: REML, restricted maximum likelihood.
confidence intervals frommodel 1 are conservative in this setting. This observationwould seem to be another consequence
of the normal approximations used in model 1 describing the data poorly in this setting.
The conclusions for the empirical standard errors of the estimates of 𝜏2 are a little more complicated. In most settings,
model 2 provides smaller empirical standard errors for 𝜏2 but the negative bias in the point estimates under this model
render this observation moot. Models 3 to 7 generally provide very similar empirical standard errors that are smaller
than those from model 1, which suggests that modelling the binomial data using generalised linear mixed models has
the potential to provide more precise estimates of 𝜏2. However, this observation is offset by the negative bias of 𝜏2 under
these models. The considerable positive bias of estimates of 𝜏2 from models 3 to 7, that is largely due to their skewness,
in setting 9 (very rare events) raises some concerns about using these models in this situation.
To illustrate the bias and precision of estimates visually, box plots of the estimators from all models in setting 1 (the
defaults) and 𝜃 = 0 are shown in Figure 1, for 𝜃 (top) and 𝜏2 (bottom). The true values of 𝜃 = 0 and 𝜏2 = 0.024 are shown
as dashed lines. Figure 1 confirms that there is little to choose between the models in terms of the point estimate of 𝜃
but also indicates that the case for the estimate of 𝜏2 is more complicated. Figure 1 captures the skewness in the point
estimates of 𝜏2. Figure 1 also illustrates the extreme negative bias of 𝜏2 under model 2 in this setting.
6.6 Coverage probability of nominal 95% confidence intervals for 𝜃
The coverage probabilities of nominal 95% confidence intervals are shown in Table 7. All models involve some form
of approximation when computing these confidence intervals; for example, models 2 to 7 use the asymptotic theory of
maximum likelihood, and so some departure from the nominal coverage probability was anticipated. With the exception
of model 2, all methods perform similarly in settings other than the challenging settings 9 (very rare events) and 15
(extreme between-study heterogeneity). It is perhaps disappointing that the generalised linear mixed models have not
resulted in amore tangible improvement in themajority of settings. As expected, confidence intervals are generally slightly
conservative in setting 2 where 𝜏2 = 0 and perform least well in settings 3 and 15 where 𝜏2 is large and extremely large,
respectively, but otherwise models 1 and models 3 to 7 generally fail to achieve the nominal coverage probability by
around 1% or 2%, asmight be expected. In setting 4, where there are just k = 3 studies, the coverage probabilities generally
appear to be a little lower than this, but given the very small number of studies, the models have performed remarkably
well. An interesting observation is that nominal 95% confidence intervals frommodel 1 are conservative in setting 9. This
is consistent with the findings of Bradburn et al40 (their figure 3) and is further evidence that normal approximations
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perform poorly in this setting. Models 2 to 7 retain the nominal coverage probability much more accurately in setting 9,
which indicates that the use of generalised linear mixed models may be especially advantageous in situations where the
events are rare. This is as might be anticipated, but this finding is somewhat offset by the conclusion that the accurate
estimation of 𝜏2 is especially challenging in this type of situation. In setting 15, models 2 to 7 fail to achieve their nominal
coverage probability by around 5%. Model 1 (REML) appears to fare slightly better in this setting but the DerSimonian
and Laird method performs worst, which is clearly a consequence of the notable downward bias of the corresponding
estimator of 𝜏2 in setting 15.
Model 2 has resulted in notable under coverage in all settings. This can be explained by the large negative bias in the
estimate of 𝜏2 in settings 1 to 14, and because all methods provide under coverage in setting 15. Although the coverage
probability for model 2 does not drop below around 84%, the general picture is that this model has performed poorly.
Another observation is that there appears to be some tendency formodel 6 to provide slightly larger coverage probabilities
that are closer to the nominal level. This model would appear to benefit from its upward bias of the estimate of 𝜏2 that we
discussed in the previous subsection.
The averagemodel-based (as reportedwhen fittingmodels) standard errors, as a percentage of the corresponding empir-
ical standard errors, are shown in parentheses in Table 7. In general, these are close to 100%, which further indicates
that the inference from our models is accurate. However, percentages in the range 80% to 90% are common from model
2, which reinforces the conclusion that this model has performed poorly. Furthermore, this ratio is 121% for model 1 in
setting 9, which is consistent with the overcoverage of nominal 95% confidence intervals for model 1 in this setting.
6.7 Robustness to the inclusion or exclusion of double-zero studies in setting 9
As explained above, in setting 9 a non-trivial number of simulated datasets contained no events. As also explained above,
by following our defaults, we included these studies when fitting models 1, 3, and 6 but it is probably better to exclude
them. We therefore refitted these 3 models in setting 9 where all double-zero studies were excluded. We found that the
differences between the results that exclude (results not shown) and include them (Tables 6 and 7 and Supporting Infor-
mation), although perceptible, were not substantial and do not alter any of the conclusions. For example, we noted above
that model 1 resulted in a bias towards the null of 0.06 to 2 decimal places when 𝜃 = log(2). It was suspected that some
of this bias towards the null may be due to including double-zero studies. This bias noticeably fell but was still 0.06 (to
2 decimal places) upon excluding these studies. This small reduction can be explained by the fact that double-zero stud-
ies are unusual when 𝜃 = log(2) in setting 9, and these studies carry relatively little weight in many analyses where 𝜏2 is
small or 0.
6.8 Conclusions from the simulation study
The finding that models 2 and 4 perform so differently raises serious concerns about modelling study specific event rates
using fixed effects. This is because apparently innocuous changes to the model result in substantial differences in the
estimation of 𝜏2. Our simulation study suggests that model 4 performs substantially better than model 2, so that until
more evidence becomes available, we suggest that model 4 should be preferred in application.
The simulation study also suggests that the recovery of intertrial information can be a potential source of bias inmodels
that insteaduse randomeffects to describe study specific event rates, butwe also conclude that this bias is likely to be small.
In practical applications, model 6 may be preferred to models 3 and 5 on the grounds that it does not place unnecessary
constraints on the covariance structure in bivariate random-effects models of this type, but this appears to come at the
price of positive bias in the estimate of 𝜏2 in most settings. However, this upward bias, although appreciable, is not very
large and somemay consider this to be a desirable consequence because this appears to result in slightly higher confidence
interval coverage probabilities for 𝜃 that are closer to the nominal level. Model 7 performs well and the information lost
by the conditioning on a statistic that is not quite ancillary appears to be negligible. However, the computation required
to fit this model can be fragile so that some statistical expertise is needed to assess this.
It is therefore not possible to recommend a single model on the grounds that it is uniformly better than others. How-
ever, since model 2 has been found to perform poorly, and model 6 appears to be a more conservative version of models 3
and 5 that places no unnecessary constraints on the covariance structure, it would seem reasonable to suggest that mod-
els 4 and 6, and also model 7 when statistical expertise is available, are all fully viable alternatives to the conventional
random-effectsmodel (model 1). Since it is evident that themodelling assumptionsmade in random-effectsmeta-analyses
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can have implications for the conclusions, themost prudent approachwould seem to be to fit several of the random-effects
models that we have proposed and assess the implications in the context of a sensitivity analysis. However, the conven-
tional model (model 1) appears to retain its usefulness because it is so simple to implement and has not been markedly
improved upon by the other models unless the event is very rare or, in the case of the DerSimonian and Laird method,
if the data are extremely heterogeneous. This is likely to be a disappointing finding for those who might advocate the
wholesale abandonment of the conventional random-effects model and the adoption of more sophisticated models such
as those we present here.
7 DISCUSSION
We have investigated the use of 7 random-effects models for meta-analysis that estimate the summary odds ratio. We
have found, through simulation and analytical investigations, that one of these models (model 2) performs poorly. Our
investigation must leave us feeling a little uncomfortable when using generalised linear mixed models for meta-analysis
that include fixed-study effects. This is because we have seen that apparently innocuous changes in the model form can
have serious consequences for maximum likelihood estimation.
An alternative is to use random-study effects, but we anticipate that some readers will object these to on the grounds
that intertrial information is then recovered. To some, it may be considered undesirable, or even nonaxiomatic, to allow
the use of intertrial information regardless of whether or not bias is invoked. We anticipate that discussion relating to this
issue will continue, where the arguments for and against random-study effects are likely to follow along the same lines
as in network meta-analysis.41,42 If random study effects are to be used then model 6 is likely to be considered preferable
to models 3 and 5, on the grounds that it is a perfectly applicable generalisation of these models that avoids making
unnecessary independence assumptions; likelihood ratio tests and Akaike information criterion statistics could be used
for determining model choice in situations where model reduction is considered desirable. Model 7 would seem to be a
desirable alternative but the numerical challenges involved in fitting thismodelmake it difficult to recommend for routine
use. If a sensitivity analysis is to be performed using a variety of statistical models, then we suggest that models 1, 4, 6,
and 7 are more than adequate for this purpose. The estimation of 𝜏2 in particular can be sensitive to the model choice,
and we advocate sensitivity analysis to explore this.
Our conclusion that model 2 performs poorly, and the consequent concerns about using fixed-study effects, has con-
siderable implications for individual patient data (IPD) meta-analyses.43 Model 2 may be extended to include study-level
covariates, and then used in a wide variety of applications of this type. Our work therefore opens up IPD meta-analyses
that have used models based on model 2 to unexpected criticism. It will be of particular interest to see how the IPD
meta-analysis community responds to our discoveries.
We have focussed on binary outcome data where the summary odds ratio is of interest. Further work should focus on
alternative measures of association, such as the relative risk, and more importantly on other forms of outcome data. For
example, generalised linearmixedmodels can be used for count data26 and linearmixedmodels can be used for continuous
data. When the outcome data are continuous, REML44 is generally preferred to maximum likelihood estimation on the
grounds that it helps to avoid the downward bias of estimated variance components. Although continuous data are not the
focus of this paper, an obvious question is whether REMLwould resolve the issues with models for continuous outcomes
that are analogous to model 2. In the Supporting Information, we extend our mathematical analysis to incorporate REML
estimation, where we find that REML does resolve these difficulties. This conclusion was confirmed in a small-scale
simulation study using continuous data, that was intended to emulate the first simulation study setting. Here, a model
for continuous data, akin to model 2, was fitted to simulated IPD using the nlme package, using syntax of the form
lme(Y ~ factor(study)+factor(treat), random = ~ treat-1|study),
where options method=“ML” and method=“REML” can be used to specify that maximum likelihood or restricted max-
imum likelihood is to be used, respectively. Models akin to model 4 can be fitted by instead specifying the option
random= treat12-1|study. Briefly, we found notable downward bias in estimates of 𝜏2 when fitting models akin to model
2 when using maximum likelihood estimation, in a similar way, as for binary outcome data in the simulation study. How-
ever, when usingmodels akin tomodel 4 usingmaximum likelihood, or REML in conjunction with amodel akin to either
model 2 or 4, there was no serious bias in this estimation. Further work that examines continuous outcome data is highly
desirable, but our analysis and small-scale simulation study indicates that the use of REML entirely avoids any serious
issues relating to bias when using fixed-study effects and the outcome data are continuous. The examination of other
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types of likelihood function is another interesting avenue for further work. In particular, alternative forms of estimation
of model 2 that, like REML, take into account the degrees of freedom lost when including many fixed effects in the model
have the potential to overcome the problems that we have encountered. We leave this as an important avenue for further
work. Another possibility to explore is the implications of themethods used to integrate out the random effects; variations
of the methods used for this will have some implications for the accuracy of the results. Further work could examine the
tradeoffs between using methods that are accurate and methods that are computationally less demanding.
In conclusion, more sophisticated models for meta-analysis, such as those that we have investigated, should be consid-
ered for use in application more often than is currently the case. In addition to highlighting some concerns about the use
of generalised linear mixed models in meta-analysis, we also hope that this paper will serve to further draw them to the
attention of applied analysts. Thesemodels have the potential to overcome some of the limitations of the current standard
approach, but they also have their disadvantages. We provide R, Stata, and SAS codes in the Supporting Information to
facilitate the use of generalised linear mixed models in applied meta-analyses.
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